Detalles de la búsqueda
1.
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.
Acta Oncol
; 62(1): 62-69, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645166
2.
Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences.
J Med Internet Res
; 22(4): e14896, 2020 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271150
3.
Danish translation, cultural adaption and initial psychometric evaluation of the patient feedback form.
Health Qual Life Outcomes
; 16(1): 77, 2018 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29703191
4.
Patient-reported outcomes used actively in cancer patients undergoing antineoplastic treatment: A mini-review of the Danish landscape.
Comput Struct Biotechnol J
; 24: 23-30, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38076643
5.
Impact of patient-reported outcomes on symptom monitoring during treatment with checkpoint inhibitors: health-related quality of life among melanoma patients in a randomized controlled trial.
J Patient Rep Outcomes
; 6(1): 8, 2022 Jan 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35061112
6.
The use of patient-reported outcomes to detect adverse events in metastatic melanoma patients receiving immunotherapy: a randomized controlled pilot trial.
J Patient Rep Outcomes
; 4(1): 88, 2020 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33125537
7.
Selection of patient reported outcomes questions reflecting symptoms for patients with metastatic melanoma receiving immunotherapy.
J Patient Rep Outcomes
; 3(1): 19, 2019 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900035
8.
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.
Adv Ther
; 30(11): 945-66, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24249433
Resultados
1 -
8
de 8
1
Próxima >
>>